Clinical profile and risk factors of steroid resistant nephrotic syndrome in an urban referral centre by Arivazhagan, R
CLINICAL PROFILE AND RISK FACTORS OF
STEROID RESISTANT NEPHROTIC SYNDROME 
IN AN URBAN REFERRAL CENTRE
Dissertation Submitted for
M.D. DEGREE EXAMINATION
BRANCH VII – PAEDIATRIC MEDICINE
INSTITUTE OF CHILD HEALTH
AND
HOSPITAL FOR CHILDREN
MADRAS MEDICAL COLLEGE
THE TAMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY
CHENNAI
MARCH – 2008
CERTIFICATE
Certified  that  this  dissertation  entitled  “CLINICAL  PROFILE  AND  RISK 
FACTORS OF STEROID RESISTANT NEPHROTIC SYNDROME IN AN URBAN 
REFERRAL CENTRE” is a bonafide work done by  Dr. R. ARIVAZHAGAN, M.D.,  
Postgraduate student of Pediatric Medicine, Institute of Child Health and Hospital for 
Children,  Egmore,   Chennai  –8  attached  to  Madras  Medical  College,  during  the 
academic year 2005-2008.
Prof. Dr. SARADHA SURESH            
                                  M.D., PhD.,FRCP.,                                                      
Director and Superintendent (I/C),
Institute of Child Health and
Hospital for Children,
Madras Medical College                                     
Chennai - 08
Prof. Dr. E. SATHYA LATHA,   
                               M.D., D.C.H.,
Professor of Pediatrics,
Institute of Child Health and
Hospital for Children,
Madras Medical College, 
Chennai - 08
Prof. Dr. PRABHA SENGUTTUVAN,   
                     M.D., D.C.H., D.M.,
Head of Dept of Pediatric Nephrology, 
Institute of Child Health and 
Hospital for Children,
Madras Medical College, 
Chennai - 08
Prof. Dr.T.P. KALANITHI           
                               M.D.,
The Dean, 
Madras Medical College,
Chennai - 03
SPECIAL ACKNOWLEDGEMENT
 My  sincere  thanks  to  Prof.Dr.T.P.  KALANITHI  M.D., the  Dean,  Madras 
Medical  College  and Research  Institute  for  allowing  me  to  do  this  dissertation  and 
utilize the institutional facilities.
ACKNOWLEDGEMENT
I  would  like  to  express  my  sincere  gratitude  to   
Prof.   Dr. SARADHASURESH, M.D., PhD., FRCP.,  Professor  of  Paediatrics,  Director  and 
Superintendent  (I/C)  of  Institute  of  Child  Health  and  Hospital  for  Children  for  permitting  me  to 
undertake this study.
I  am extremely  thankful  to  Prof.  Dr.  E.  SATHYA LATHA, M.D.,  D.C.H., Professor  of 
Pediatrics and our unit chief for her guidance, invaluable help, encouragement and support throughout 
the study.
I  am  extremely  thankful  to  Prof.  Dr.  PRABHA  SENGUTTUVAN, M.D., 
D.C.H.,  D.M.   Head  of  the  Department  of  Pediatric  Nephrology  for  her  guidance, 
invaluable help, encouragement and support throughout the study.
I would like to thank my unit Assistant Professors of Paediatrics,  Dr.R. SOMASEKAR, M.D., 
D.C.H.,   Dr.  KUMARESAN,  DCH.,DNB.  Dr.  N. RATHINAVELU, M.D.,  and  Dr.  S.  BALA 
MEENA M.D., D.C.H., D.M. for their valuable guidance and assistance in doing this work.
I would like to thank  Dr. K.  NEDUNCHELIAN M.D., D.C.H.,  for his valuable suggestion 
and guidance in doing this study. 
I  express  my  sincere  thanks  to  Dr.  PADMARAJ,  M.D.,  D.C.H., D.M.  (Nephro)., and 
Dr.MATHIVANAN, M.D.,DCH for their valuable suggestion and guidance in doing this work. 
I extend my sincere thanks to Dr. P. RAMACHANDRAN,        M.D., D.C.H., Registrar for 
his valuable suggestion and guidance in doing this work. 
I sincerely thank all the children and their parents who had submitted themselves for this study 
without whom this study would not have been possible. 
CONTENTS 
SL.NO. TITLE PAGE NO.
I. INTRODUCTION 1
II REVIEW OF LITERATURE 18
III STUDY JUSTIFICATION 25
IV AIM OF THE STUDY 26
V SUBJECTS AND METHODS 27
VI OBSERVATION AND DISCUSSION 34
VII SUMMARY 50
VIII CONCLUSION 52
BIBLIOGRAPHY
INTRODUCTION
The  term  nephrosis,  or  nephrotic  syndrome,  had  its  origin  in  the  early  20th 
century and was introduced primarily to distinguish it from nephritis, a label used to 
denote a clinical state associated with hematuria, proteinuria, and cellular proliferation 
of the glomerulus. It describes a clinical condition of edema and proteinuria in which the 
renal  histology  (light  microscopy)  demonstrates  fatty  degeneration  of  the  tubules 
associated with normal appearing glomeruli. Briefly, the name was modified to lipoid 
nephrosis after the routine finding of lipid droplets in the urine of affected patients.
Nephrotic syndrome is characterized by heavy proteinuria (>3.5 gm/day in adults 
or 40mg/m2/hr in children), hypoalbuminemia (<2.5 gm/dl), edema and hyperlipidemia 
(1). It is primarily a pediatric disorder and is 15 times more common in children than 
adults. 
Etiology
Most  children  (90%)  with  Nephrotic  syndrome  have  a  form  of  the  primary 
Nephrotic  syndrome.  10%  of  children  with  Nephrotic  syndrome  have  secondary 
Nephrotic syndrome (2)
A. Causes of primary Nephrotic syndrome includes  
1. Minimal change nephrotic syndrome (MCN) (85%)
2. Mesangial proliferation (5%)
3. Focal segmental glomerulo sclerosis (FSGS) (10%) 
4. Membranous nephropathy (MGN)
5. Membranoproliferative glomerulonephritis (MPGN).
B.Secondary nephrotic syndrome causes include
1. Henoch-scholein purpura
2. SLE
3. Vasculitis
4. Polyarteritis nodosa
5. Wegener’s granulomatosis
6.  Systemic infections
- post streptococcal GN
- Hepatitis B
- Congenital or secondary syphilis
- Ventriculo atrial shunt
- Subacute bacterial endocarditis
- HIV
- Malaria
7.  Drugs 
- Gold
- D-penicillamine
- Captopril
8.  Neoplasms
       - Hodgkin’s diseas
9.  Sickle cell anemia
10. Diabetes
C. Congenital nephrotic syndrome 
Sex
In children having onset less than 8 years, the ratio of males to females varies 
from 2:1 to 3:2 in various studies (3). In older children, adolescents and adults, the male 
to female prevalence is approximately equal. ISKDC data indicate that 66% of patients 
with either MCNS or FSGS are male, whereas, for MPGN, 65% are female (4). 
Age 
In children who develop NS while younger than 18 years, approximately 75% are 
under the age of 6 years with peak incidence between 2-3 years (5). The younger the child 
at onset (with the exception of the first few months of life), the greater the likelihood 
that the lesion is MCN (6). With onset before age 5 years, the likelihood is >90%; the risk 
for FSGS and MPGN is 7% and 1%, respectively. Conversely, with onset after age 10, 
the risk for MCN drops to ~50%, and the risk for FSGS and MPGN is almost 30% and 
20%, respectively.
The overall prevalence of NS in childhood is approximately 2-5 cases per 100,000 
children. The cumulative prevalence rate is approximately 15.5/100,000 (7).
 MCN is  the  most  common  form in  children,  and  its  prevalence  is  inversely 
proportional to the age at onset (i.e. the younger the child, the more likely the histology 
will  show  minimal  abnormalities  on  light  microscopic  evaluation  of  glomerular 
histology)(8).  Histologic  variations  exist  within  this  category  in  which  some patients 
demonstrate only fusion and smudging of the epithelial cell podocytes while others may 
demonstrate  mild  changes  within  the  glomerular  mesangium  consisting  of  either 
proliferation  or  sclerosis.  Since  patients  with  MCN  have  the  highest  rate  of 
responsiveness to standard therapy and the best long-term prognosis, the separation of 
MCN from others is important (9). 
IgM mesangial  nephropathy (IgM nephropathy) may be a separate entity from 
MCN. Assignment of type of NS by histologic criteria is based predominately on light 
microscopic  findings.  Most  patients  with isolated IgM mesangial  immunofluorescent 
staining present with clinical characteristics similar to those with MCN. Whether the 
finding  of  immune  deposits  of  IgM alters  either  response  to  therapy  or  subsequent 
course is controversial. 
FSGS is the second commonest type of histologic subtype seen in children and 
appears to be increasing in frequency (10). 
It is not a single disease entity, and attempts to portray it as a uniform entity has 
led to some confusion in the literature with regard to natural history. FSGS is always a 
histopathologic  diagnosis,  and  its  clinical  presentation  will  vary  according  to  the 
etiology  or  cause  of  the  histologic  lesion.  FSGS may  manifest  in  a  fashion  that  is 
indistinguishable from MCN, but it may be found only after years of clinical nephrotic 
syndrome  when  earlier  biopsies  have  been  interpreted  as  MCN.  FSGS is  a  known 
consequence of hyper filtration and is regularly seen in patients with reflux nephropathy 
and  in  some  patients  with  a  single  kidney  who’s  other  has  been  lost  because  of 
conditions such as multicystic dysplastic kidney disease. 
Membranoproliferative  glomerulonephritis  (MPGN) may  manifest  as  nephrotic 
syndrome,  particularly  in  older  children and adolescents.  Its  clinical  picture  is  more 
closely associated with a nephritic  picture, but on occasion it  may appear similar to 
MCN or FSGS. Membranous glomerulonephritis (MGN) accounts for less than 1% of 
the cases of NS in childhood and adolescence and is often associated with hepatitis or 
other viral disease (11).
Congenital nephrotic syndrome becomes a consideration when nephrosis appears 
during the first  year  of  life  and particularly  in those instances in  which the clinical 
syndrome starts in the first few months. 
Pathophysiology 
Proteinuria
Heavy proteinuria (albuminuria) is the hallmark of this condition and the primary 
abnormality  in  NS. The degree of  proteinuria  varies  considerably  from one child to 
another.  Some children will  excrete  as  much as 15 g/m2/24 hours,  and the minimal 
excretion compatible with the diagnosis is around 1 g/m2/24 hours (approximately 40 
mg/m2 /hour). 
The  initiating  event  that  produces  proteinuria  remains  unknown.  Primary 
nephrotic syndrome is believed to have an immune pathogenesis, but the precise nature 
of the process has yet to be defined. It is relation to lymphocyte dysfunction has been 
suggested,  and  various  studies  lend  credence  to  this  hypothesis.  A  highly  cationic 
plasma protein that may neutralize the anionic charge on the glomerular capillary wall 
has been described in nephrotic children.
Other investigators have noted a decrease in immune responsiveness and related 
this to alterations in either T-lymphocyte number and/or function(12,13). The presence of 
suppresser cytokines or lymphokines has been postulated, and various investigators have 
shown  changes  in  interleukin-8,  interferon- ,  IGF-1,  TGF-Alfa,  and  vascular  
permeability factor (VPF) (14). The role of the kinin system is also under investigation, 
because urinary excretion of kinins is  increased during exacerbations of the disease. 
More recently, alterations in certain molecules expressed in the epithelial cell podocyte, 
especially  nephrin,  podocin,  and  actin,  have  been  shown  to  have  a  role  in  the 
pathogenesis  of  the  proteinuria  (15).  Other  researchers  have  not  felt  nephrin  to  be 
involved in children with MCN. The rate of apoptosis in circulating T-lymphocytes has 
been  found  to  be  increased,  and  a  role  for  reduced  antioxidant  defense  has  been 
postulated. Despite the regular finding of elevated levels of IgE and an association with 
atopy  in  steroid-responsive  NS,  current  data  merely  suggest  a  common  immune 
activation rather than a direct association. Leptin is now being investigated for its role in 
the pathogenesis since, in MCN; serum levels are low at onset of the disease and are 
associated with elevated serum levels of TGF alfa 1. Additionally, some evidence still 
exists that genetic factors may be involved in the pathogenesis (16)
In primary nephrotic syndrome, the glomerular capillary permeability to albumin 
is selectively increased, and this increase in filtered load overcomes the modest ability of 
the tubules to reabsorb protein. This selective proteinuria (as seen in MCN) is quite 
different  from  the  more  nonselective  proteinuria  observed  in  cases  of 
glomerulonephritis.  Part of this increase in albumin excretion may be because of the 
smaller  size  of  the albumin molecule,  but  since the excretion of  some even smaller 
weight plasma proteins is not proportionally increased, the presence of other factors is 
obvious. At least 2 hypotheses are proposed to account for this increased permeability. 
The  traditional  hypothesis  relates  to  changes  in  the  anionic  composition  of  the 
glomerular basement membrane (GBM). In the normal state, the endothelial side of the 
glomerular capillary wall is negatively charged because of the presence of  variety of 
polyanions  along this  surface.  Thus,  the negatively-charged protein,  albumin,  is  less 
likely to be filtered (17). 
In experimental nephrosis and in some children with primary NS, studies have 
demonstrated  a  decrease  in  the  normal  content  of  sialic  acid  (polyanion)  from the 
basement  membrane.  While  such  has  not  been  confirmed  by  all  investigators,  this 
deficiency may allow for an increased transport of anionic plasma components.
In such a state,  permeability  of  the glomerular  basement  membrane would be 
selectively altered, increasing capillary transport of anionically charged particles such as 
albumin.
 An alternative proposal to explain the heavy proteinuria invokes a primary role for 
the epithelial cell podocytes. Flattening, retraction, and effacement of the podocyte foot 
processes are a constant feature of heavy proteinuria. 
In the traditional viewpoint, these changes are considered as consequences of the 
proteinuria.  Other investigators believe that primary distortions of the slit  diaphragm 
filaments are present and that there is a redistribution of nephrin from the podocyte slit 
pores into the cytoplasm. 
Hypoalbuminemia is  the result  of  the increased urinary loss  of  protein.  Other 
factors,  however,  may  contribute  to  the  hypoalbuminemia,  among  them  decreased 
synthesis, increased catabolism, and increased gastrointestinal losses. Even though most 
studies have shown that  the albumin synthesis  rate  is  not  decreased,  the capacity to 
increase  hepatic  production  appears  insufficient  to  compensate  for  the  large  urinary 
losses (18). 
Edema 
Edema  appears  to  be  the  natural  consequence  of  the  hypoalbuminemia.  The 
classic explanation for edema formation is a decrease in plasma oncotic pressure (as a 
consequence of low serum albumin) causing an extravasation of plasma water into the 
interstitial space. The resulting contraction in plasma volume would theoretically lead to 
a decrease in renal perfusion and hence to stimulation of the renin-angiotensin system 
(19).  This  hormonal  effect  coupled with an increase in  the synthesis  and secretion of 
antidiuretic hormone (related to the decrease in effective plasma volume) would lead to 
an increase in renal tubular  reabsorption of sodium and water.  The net  result  of the 
combination  of  Starling  forces,  reduction  in  renal  perfusion  (GFR),  and  increased 
hormonal  activity  would be avid reabsorption of  both sodium and water,  leading to 
either maintenance or furthering of the edema (20). 
While the above hypothesis on the pathogenesis of edema is attractive, certain 
experimental data do not completely support this traditional concept. First, the plasma 
volume has  not  always  been found to  be decreased  (21) and,  in  fact,  in  most  adults, 
measurements of plasma volume have shown to be increased. 
Most (but not all) studies demonstrated a reduced plasma volume only in young 
children with MCNS. Additionally, most studies have failed to document elevated levels 
of renin, angiotensin, or aldosterone, even during times of avid sodium retention. Active 
sodium reabsorption also continues despite actions that should suppress renin effects 
(i.e., albumin infusion, 
ACEI administration). Coupled with these discrepancies is the fact that, in the 
steroid-responsive nephrotic syndrome, diuresis usually begins before plasma albumin 
has  significantly  increased  and  before  plasma  oncotic  pressure  has  changed.  Some 
investigators have demonstrated a blunted responsiveness to atrial  natriuretic peptide 
(ANP) despite higher than normal circulating plasma levels of ANP. 
Thus, that the precise cause of the edema and its persistence is uncertain should be 
apparent. A complex interplay of a variety of physiologic factors (i.e., decreased oncotic 
pressure, increased activity of aldosterone and vasopressin, diminished atrial natriuretic 
hormone,  activities  of  various  cytokines  and  physical  factors  within  the  vasa  recti) 
probably contribute to the accumulation and maintenance of edema. 
Hyperlipidemia
Cholesterol levels are usually consistently elevated and an inverse relationship of 
cholesterol  and albumin is well  known  (22).  Serum HDL levels  are  low  (23).  60 % of 
nephrotics have type IIa or IIb type of hyperlipidemia, 30 % have type V and 10 % or 
less have type III or IV. 
Both  increased  hepatic  synthesis  (triggered  by hypoalbuminemia)  and reduced 
lipoprotein lipase levels  are thought to be the cause for  hyperlipidemia.  The risk of 
future atherosclerosis may be increased (22). 
Clinical features
Regardless  of  the  type  of  NS  (the  histopathologic  type),  the  major  clinical 
manifestation is edema, which is the presenting symptom in about 95% of children. The 
edema in the early phase is intermittent and insidious; even its very presence may not be 
appreciated. It  usually appears first  in areas of low tissue resistance (i.e.,  periorbital, 
scrotal, and labial regions) and may progress either rapidly or quite slowly. Ultimately, it 
becomes generalized and can be massive (anasarca). It is typically dependent in nature, 
more noticeable in the face in the morning (upon arising) and predominately in lower 
extremities later in the day. It is pitting in nature. In cases with marked edema, the skin 
may ooze clear fluid and appear thinner than usual. 
An occasional child with NS will present with gross hematuria. The frequency of 
macrohematuria depends on the histologic subtype of NS. It is more common in those 
patients with MPGN than in other causes, but its frequency in MCNS has been reported 
to be as high as 3-4% of cases. Statistically, a higher percentage of patients with FSGS 
have microhematuria than those with MCNS, but this is not helpful in differentiating 
between  types  of  NS  in  the  individual  patient.  Oliguria  is  a  common  occurrence 
irrespective of the etiology (23). 
Regardless of the type of NS, anorexia, irritability, fatigue, abdominal discomfort, 
and diarrhea are common. If ascites is marked, respiratory distress is not uncommon. An 
occasional child will present with fever and septic picture; the peritoneum is often the 
site  of  the  infection.  Streptococcus  pneumoniae  is  the  most  frequent  organism 
responsible for peritonitis in this population, but Staphylococcus aureus and Escherichia 
coli are commonly recovered. Symptoms of a urinary tract infection are occasionally 
present. 
A history of a respiratory tract infection immediately preceding the first clinical 
signs of the disease is frequent, but the relevance to causation is uncertain. A history of 
prior allergic events is common, and atopy has been reported in approximately 40-50% 
of children with MCN (24). 
Treatment
In  children  with  presumed  minimal  change  disease  Prednisolone  should  be 
administered at a dose of 2 mg/kg/day (60mg/m2/day) in 2 or 3 doses for  4 to 6 weeks 
then the dose should be tapered to 40mg/m2/day given every other day. Alternate day 
dose is tapered and stopped over 2 to 3 months (35).
Cyclophosphamide  has  been  shown  to  prolong  the  remission  and  reduce  the 
number of relapses (36). 
Other  drugs  tried  in  the  treatment  of  complicated  nephrotic  syndrome mainly 
steroid  resistant  nephrotic  syndrome  are  cyclosporine  (37),  tacrolimus  (38),  and 
mycophenolate.
ACE inhibitors may be used to reduce the proteinuria (39).  
Congenital Nephrotic Syndrome
Infants  who  develop  nephrotic  syndrome  within  the  first  3  mo  of  life  are 
considered to  have congenital  nephrotic  syndrome.  The  most  common cause of  this 
syndrome  is  Finnish  type  congenital  nephrotic  syndrome,  an  autosomal  recessive 
disorder  that  is  most  common  in  populations  of  Scandinavian  descent  (1:8,000 
incidence). 
This type of congenital nephrotic syndrome is caused by a mutation in the NPHS1 
gene located on chromosome 19, which encodes a protein, nephrin. Nephrin is a key 
component of the slit diaphragm of the glomerular epithelial cell and is thought to play 
an essential role in the normal function of the glomerular filtration barrier. 
The major pathologic features of the Finnish type of this syndrome are dilatation 
of the proximal tubules,  mesangial  hypercellularity,  and glomerular sclerosis.  Infants 
with the Finnish type of congenital nephrotic syndrome present with massive proteinuria 
(detectable in utero by increased a-fetoprotein), a large placenta, and marked edema. 
Additional clinical features include prematurity, respiratory distress, and separation of 
the  cranial  sutures.  The  natural  history  of  the  disease  is  one  of  persistent  edema, 
recurrent  infections,  and  progressive  renal  failure  with  death  by  the  age  of  5  yr. 
Corticosteroids and immunosuppressive agents are of no value.
ACE  inhibitors,  indomethacin,  and  unilateral  nephrectomy  may  diminish 
proteinuria and ameliorate the nephrotic state. However, the preferred treatment includes 
bilateral  nephrectomy,  chronic  dialysis,  aggressive  nutritional  support,  and  eventual 
kidney transplantation. In families at risk for the Finnish type of congenital nephrotic 
syndrome,  antenatal  diagnosis  is  suggested  by  an  elevated  amniotic  fluid  
a-fetoprotein level and the diagnosis may be confirmed by DNA analysis.
Other causes of congenital nephrotic syndrome include congenital infections such 
as syphilis, toxoplasmosis, rubella, and cytomegalovirus. HIV and hepatitis B have also 
been reported to cause nephrotic syndrome in the neonatal period. The nephrotic state, 
which is generally less severe than the Finnish type of congenital nephrotic syndrome, 
may improve or resolve with treatment of the underlying infection.
Diffuse mesangial  sclerosis  is  a  rare glomerular  disease seen in  a  minority  of 
children with congenital nephrotic syndrome. The characteristic pathologic finding is 
progressive sclerosis of the glomerular mesangium, and the clinical picture is one of 
rapid loss of renal function, with end-stage renal disease developing within months to 
years. Diffuse mesangial sclerosis may occur as an isolated disease or as part of Denys-
Drash  syndrome,  a  condition  also  characterized  by  Wilms  tumor  and  male 
pseudohermaphroditism,  caused  by  a  mutation  in  the  Wilms  tumor  gene  (WT1)  on 
chromosome 11.
                         REVIEW OF LITERATURE
The incidence of nephrotic syndrome in western countries varies between  2 to 
2.5/100,000children per year (25) 
Srivasthava reported a incidence of 1.4% among pediatric patients  in India(7) 
Age and sex
Prospective studies by ISKDC from 1967-1976 reported that 60% of children with 
MCD were 2-6 years of age (9).
White  (1970)  (26) reported  a  male  to  female  ratio  2:1  which  diminishes  with 
advancing age.
Srivasthava et al (27) studied 206 cases and found that male to female ratio was 3:1 
in younger children and 7:1 in older children. But generally children with SRNS have 
higher age of onset {8.2 years (26)}
In  80  to  85  % of  children,  nephrotic  syndrome  results  from MCD  which  is 
generally steroid responsive (28). But this high incidence of primary nephrotic syndrome 
due to MCD may not be applicable to all societies. 
For example most nephrotic African children have obvious structural glomerular 
lesions and are unresponsive to steroids (29). 
All the studies done in nephrotic syndrome so far showed, that the children with 
nephrotic syndrome other than MCN poorly respond to steroids. Even in MCN about 
10% of cases are resistant (30) 
Alexandru  R.  Constantinescu,  Hetal  B.  Shah,  Edward  F.  Foote,  and Lynne S. 
Weiss et al (31) From the   Department of Pediatrics, Division of Pediatric Nephrology, 
University of Medicine and Dentistry of New Jersey-Robert  Wood Johnson Medical 
School, New Brunswick, New Jersey; They did a prospective study to identify factors at 
initial presentation that could predict the relapse and resistant pattern in the first year 
after  diagnosis,  without  taking  into  consideration  the  histopathology  found  on  renal 
biopsy.  Variables selected in the study were age, sex,  race,  presence or  absence of 
hematuria, and days to remission.
Results:   Of  70 patients,  14 were excluded because of  insufficient  data.  There 
were 38 males (67.9%) and 18 females (32.1%), giving a male: female ratio of 1.8:1. 
Median age at presentation was 3.25 years (range:  1.5-13). Of all the patients, 23 were 
infrequent  relapse  (41.1%),  9 were  frequent  relapse  (16.1%),  and  24 were  Steroid 
dependant (42.9%). Hematuria was present initially in 26 patients (46.4%), and absent in 
30 (53.6%). Age, sex, race, and hematuria, as independent variables, were not predictors 
of relapses in the first year. However, using a stratified analysis based on the presence or 
absence of hematuria, we found that if the remission occurred within the first week of 
therapy, the patients without hematuria were more likely to be infrequent relaps. The 
sensitivity and specificity of this finding was 67% and 89%, respectively, with a positive 
predictive value of 94%. 
Conclusion of this study was the rapidity of initial  response to steroid therapy 
combined with the presence of hematuria could predict future relapses and should be 
well documented.
Hideo shiiki and Kazuhiro et al  (40) from Nara medical university did a study on 
clinical course, predictors of renal outcome in patients with steroid resistant nephrotic 
syndrome  when   clinical  and  histopathological  features  at  presentation  have  been 
evaluated by multivariate analysis, serum creatinine concentrations (>1.5 mg/dl) and the 
presence  of  tubulo-interstitial  lesions  (>20%)  are  significant  positive  predictors  of 
progression to ESRD.
Histopathological distribution of nephritic syndrome 
Type White et al(26)
Habib 
et al.,(41) ISKDC  
(4) ICH & HC 
(44)
MCD 76.5% 51.5% 76.4% 62.2 %
FSGN 8.2% 11.5% 6.9% 12.4 %
MGN 1.3% 8% 6.9% 2.1 %
MPGN 6.2% 13% 7.5% 7.8 %
OTHERS 5% 13.5% 7.7% 6.0 %
DMP 2.8% 1% 0% 15.9 %
Vipul c.chitalia et al.,(42) did a retrospective study to predict the renal survival in 
focal glomerulosclerosis on 111 patients who were diagnosed at Christchurch hospital 
from 1965 to 1998.  the predictors of  outcome included age,  gender,  blood pressure, 
serum albumin, plasma creatinine, presence of hematuria and amount of proteinuria ( at 
the time of presentation).An injury score (combination of  % of sclerosed glomeruli and 
proportion of tubulointerstitial fibrosis ) was derived from a review of the initial renal 
biopsy. The median renal survival was 16.4 years. The best single variable model was 
that  using the proportion of  tubulointerstitial  fibrosis.  However,  inclusion  of  plasma 
creatinine significantly improved the fit of the model. 
South  west  pediatric  nephrology  study  group  (34) prospectively  monitored  75 
pediatric patients with FSGS most  of whom were treated with steroids after a mean 
follow-up of 57 months. 21% of these patients developed ESRD among which 23% had 
decreased GFR and 33% had persistent proteinuria. Only 11% went into remission.
Nesrin Besbas, Rezan Topaloglu, Omit Saatci,  Aysin Bakkaloglu et al (43) from 
the  Department  of  Pediatric  Nephrology,  Hacettepe  University  School  of  Medicine, 
Ankara, Turkey did a prospective long term follow up study of children with steroid 
resistant nephrotic syndrome. Out of 215 children with steroid-resistant primary NS, 164 
had been followed from    1 to 10 years. The children had a mean age of 8.2 years, with 
a range from 1 to 16 years. Steroid resistance was more common in children over six 
years of age compared with the other age groups. Hematuria was seen in 68 of the 164 
children  (41%);  hypertension  in  41  (25%);  and  hyperlipidemia  in  112  (68%). 
Hypocomplementemia was noted in 24 of the 65 (37%) children in whom complement 
concentrations were determined. Renal biopsy was performed in 117 of the children. 
Pathologic changes consisted of minimal change nephrotic syndrome (MCNS) in 
14  children  (12%),  membranoproliferative  glomerulonephritis  (MPGN) in  45 (38%), 
focal segmental glomerulosclerosis (FSGS) in       20 (25%), mesangial proliferation 
(MP)  in  23  (20%),  and  membranous  glomerulonephritis  in  6  children  (5%). 
Cyclophosphamide (2 mg/kg/day) was given to 164 patients, with complete remission 
and  partial  remission  rates  of  20.7%  (34  of  164  children)  and  24.4%  (40  of  164 
children), respectively. 
In this group, sustained remission and sustained partial remission rates were found 
in 20% (32 children) and 13% (21 children), respectively. Chlorambucil was given to 40 
children with steroid- and cyclophosphamide-resistant nephrotic syndrome, with total 
remission and partial remission rates of 20% (eight children), and 12.5% (five children), 
respectively. These rates did not change during the follow-up. Thus, cyclophosphamide 
is  valuable  in  the  treatment  of  children  with  steroid-resistant  NS with  a  variety  of 
histologic changes (32)
Treatment 
The ISKDC reports that 91.8% of patients who responded had minimal-change 
glomerulonephritis, compared with only 25% of patients who did not respond.
In patients who do not respond to corticosteroid treatment and are younger than 6 
years, approximately 50% had minimal-change  glomerulonephritis; in those older than 
6 years, only 3.6% had minimal-change glomerulonephritis.
The Southwest Pediatric Nephrology Study Group reports that 63% of patients 
with diffuse membranous hypercellularity and approximately 30% of patients with focal 
glomerular sclerosis responded to corticosteroid therapy. Congenital nephrotic syndrome 
is usually resistant to corticosteroid treatment.(34)
STUDY JUSTIFICATION
Steroid Resistant-Nephrotic Syndrome (SRNS) is a chronic, progressive disorder 
a relatively uncommon renal disease in children, affecting up to 20% of all children with 
NS. Of these, most will have FSGS on biopsy, with smaller number having MCN. It 
causes morbidity and mortality due to persistent edema, hypertension, hyperlipidemia, 
thrombosis and infection. Progression to renal failure was thought to be inevitable in 
survivors. Recent insights into the pathogenesis of the disease have identified several 
responsible genes and proteins. Although numerous treatment regimens have been used, 
approximately 70% of FSGS are unresponsive to steroids, and no other regimen has 
been found that adequately treats SRNS and FSGS. Because of the lack of effective 
treatment and the poor prognosis with progression to chronic renal insufficiency and end 
stage  renal  disease,  SRNS represents  a  significant  therapeutic  dilemma for  pediatric 
nephrologists. Hence this study has been concentrated mainly on children with SRNS 
but at the same time, those children with steroid responsive nephrotic syndrome have 
been studied since this group constitutes the major type. 
AIM OF THE STUDY
1. To find out the incidence, age and sex distribution and also the distribution 
of various types of steroid resistant nephrotic syndrome in a given period.
2. Predictors  of  the  response  to  steroids  from  clinical,  biochemical  and 
radiological characteristics of children presenting with features of nephrotic 
syndrome.
3. To find out the histopathological type in steroid resistant cases. 
SUBJECTS AND METHODS
Study design
Prospective case study, conducted in the Department of nephrology, Institute of 
child health, Chennai.
Study period: 
Jan 2006 to Sep 2007
Study place
Institute of child health and Hospital for children
Study population 
Children attending the nephrology outpatient department who fulfill the criteria of 
nephrotic syndrome and who had undergone treatment for at least 6 weeks of steroid 
were included. 
Diagnostic criteria for nephrotic syndrome 
ISKDC defines nephrotic syndrome as 
1. Massive proteinuria of 40mg/m2/hr,
2.  Hypoalbuminemia <2.5 gm/dl 
3.  Hypercholesterolemia >220mg /dl and with or without edema.
4.  Spot protein creatinine ratio >3.5
5.  24 hour urine protein >50mg/kg/day 
Maneuver
Clinical data 
Complete history was obtained from parents regarding the illness from onset. A 
detailed clinical examination and laboratory evaluation was done in all  patients with 
special  emphasis  on  unusual  features  like  high  Blood  Pressure,  hematuria,  and 
infections.
Follow up
All newly diagnosed NS cases were followed every 2 weeks. They were treated 
with steroids as per APN regime. The parents were given clear instructions on diet and 
as to how to take the drugs. 
Response to steroids was monitored with urine albumin  and more than 2+ was 
taken as significant proteinuria.
All  these  children  were  followed-up  for  8  weeks.  After  8  weeks  Steroid 
responders were released from follow-up. Those children with SRNS  underwent renal 
biopsy and histopathology and were entered.
Investigations
Urine
Heat coagulation method was done to detect proteinuria. Urine microscopy and 
culture was sent at initial presentation and also during subsequent relapses. 
Spot urine protein/creatinine and 24 hours urine protein estimation was done for 
all the patients who got admitted during the first or subsequent visits and only spot urine 
protein/creatinine was estimated for the patients who came with a relapse and got treated 
as outpatients.
Blood biochemistry
Blood urea,  serum creatinine,  serum electrolytes  (Na,  K,  Ca and Po4)   serum 
protein (total, albumin, globulin) and serum cholesterol was estimated for the children 
who got admitted for the first visit and also during the subsequent visits when necessary.
ANA titer was done whenever necessary. Australia antigen was tested for all the 
patients whenever the kit was available.
Routine hemogram, Mantoux test and x-ray chest were done for all the patients 
before starting them on steroids. For patients taking cyclophospamide weekly hemogram 
was done.
Ultrasound
Ultra sonogram of the kidney was done for all the patients during first admission 
and they were classified into 4 groups
1. Normal study- Renal cortical echo texture is less than that of liver parenchymal 
echo texture.
2. Grade I RPD (renal parenchymal disease)- renal cortical echo texture is equal to 
that of liver parenchymal echo texture.
3. Grade  II  RPD-  renal  cortical  echo  texture  is  more  than  that  of     liver 
parenchymal echo texture.
4. Grade III RPD-renal parenchymal (cortex and medulla) echo texture is more than 
that  of  liver  parenchymal  echo  texture,  with  loss  of  corticomedullary 
differentiation.
Renal biopsy
       Written consent was obtained from the parents before biopsy. Biopsy was done 
under local anesthesia with a trucut needle or biopsy gun under strict aseptic precautions 
after localizing the site of the renal biopsy by ultrasound and after ruling out coagulation 
abnormalities.
The indications for doing a renal biopsy were: 
1. Atypical  presentation-  gross  hematuria,  persistent  hypertension  or  renal 
failure.
2. Steroid resistant nephrotic syndrome.
3. Steroid dependent nephrotic syndrome.
4. Frequent relapses.
5. Before starting cytotoxic drug therapy.
6. Systemic manifestations.
But biopsy could not be done for all  the patients mentioned above because of 
various reasons due to unwillingness of the parents for biopsy or presence of infection at 
that time, etc.
Treatment 
           All the patients with the first episode of nephrotic syndrome were admitted for 
investigations  and  treatment.  Patients  with  a  focus  of  sepsis  were  treated  with 
appropriate antibiotics prior to steroid therapy. And subsequently  were started on the 
following regime.
Prednisolone 2 mg/kg/day (maximum 60mg) in divided doses was given for 4 
weeks.  After  that  the same dose was given as a single dose on alternate days for  4 
weeks. Then the dose was tapered by 10mg every 2 weeks.
The course after the therapy was defined as follows:
1) Remission 
           A reduction in the urinary protein excretion to trace or nil by heat coagulation 
method for three consecutive days.
2) Relapse             
           Appearance of proteinuria (2+ or more) for three consecutive days after a period 
of response for at least 4 weeks.
Frequent relapse 
           Any responder who had two or more relapses within 6 months of the initial 
response or three relapses within one year period
3) Steroid depender
           Patients who need prolonged and continued maintenance of steroid therapy. 
Discontinuation or reduction in the dose results in relapse of proteinuria within 2 weeks. 
4) Steroid resistant
           Persistent proteinuria (2+ or more) after 8 weeks of daily divided doses of steroid.
Treatment of Steroid resistant cases 
If  there  is  persistent  proteinuria  even  after  4  weeks  of  daily  steroids  (2 
mg/kg/day), then the same dose is continued daily for another 4 weeks. If there is no 
remission even after 8 weeks of full dose of steroids, it is labeled as steroid resistant 
nephrotic syndrome. In these cases, the dose of Prednisolone is tapered to 0.5mg/kg and 
continued. Simultaneously         i.v cyclophospamide was added in a dose of 500 mg/m2 
and 6 monthly pulses were given.
Other drugs that we are using in our hospital include Methyl Prednisolone, ACE 
inhibitors like Enalapril to reduce the proteinuria and newer drugs like Tacrolimus.
Hypertension  was  treated  with  alpha  methyl  dopa  in  the  dose  of  10  to  20 
mg/kg/day in divided doses. Renal failure was treated conservatively and if failed then 
peritoneal dialysis was done.
Diet 
All patients were given a normal protein diet of high biological value with no 
added salt. In the presence of severe edema salt restricted diet was given in addition to 
furosemide or spiranolactone or fresh frozen plasma. 
OBSERVATION AND DISCUSSION
Types of nephrotic syndrome
Table 1
Type N %
Steroid responsive nephrotic syndrome 112 60.5
Infrequent relapse 21 11.4
Frequent relapse 6 3.2
Steroid dependant nephrotic syndrome 24 13.0
Steroid resistant nephrotic syndrome. 22 11.9
Total no of patients 185 100
In our hospital, nephrotic syndrome constitutes 9% of the patients attending the 
nephrology  out  patient  department.  This  is  the  second  commonest  renal  problem in 
children,  the first  being acute  nephritic  syndrome.  The incidence of  steroid resistant 
nephrotic  syndrome  in  our  study  was  11.9%  (22).  Steroid  responsive  nephrotic 
syndrome is the predominant type with 60.5% (112), steroid dependant type follows 
with 13% (24) and significant number of children developed relapses 14.6% (27).
 Among the relapse group 11.4% (21) children had infrequent relapse. In our study 
2 children had secondary nephrotic syndrome, one due to Hodgkin’s lymphoma who 
responded well to steroids now under follow up in hematology department and another 
had Systemic lupus erythematosis who was lost to follow up.
Nephrotic syndrome age distribution
Table 2
Age n %
<1 year 6 3.2
1 – 3 years 74 40.0
4 – 6 years 50 27.0
7 – 9 years 40 21.6
10 – 12 years 15 8.1
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Steroid resistant & responsive Nephrotic syndrome age distribution
Table 3
Age
Steroid resistant (n=22) Steroid responsive(n=112)
Number % Number %
<1 year 1 4.5 3 2.5
1 – 3 years 8 36 42 37.5
4 – 6 years 7 32 32 28.5
7 – 9 years 5 23 23 20.5
10-12years 1 4.5 12 11
In this study, mean age at presentation was 4 years for both steroid responsive and 
resistant group. The range is from birth to 12 years. Older age of onset for SRNS has 
been noticed in various studies however has not been found in our study. In our study no 
congenital nephrotic syndrome was reported.    
Sex distribution of nephrotic syndrome
Sex distribution Steroid resistant & responsive nephrotic syndrome
Table 4
Sex
Steroid resistant (n=22) Steroid responsive (n=112)
Cases % Cases %
Male 14 64 73 65
Female 8 36 39 35
Sex distribution
          The overall male to female ratio in this study is 2:1. Both the groups show male 
predominance. Male predominance was reported in a number of other studies too. 
63%
37%
MALE FEMALE
          White (1970) reported a male to female ratio 2:1 which diminishes with advancing 
age.
Srivasthava et al reported a male to female ratio of 3:1 in younger children and 
7:1 in older children. 
Family history
          Family history of  nephrotic  syndrome was noticed in  2 patients  with resistant 
group (both DMP) and in 3 patients with responsive group.
This is in contrast to the study by Habib et al., in which FSGS is the common 
lesion in familial nephrotic syndrome.
Atypical features in steroid resistant and steroid 
responsive nephrotic syndrome
Table 5
S.NO. Features
Resistant (n=22) Responsive (n=112)
No of cases % No of cases %
1. Hematuria 7 32% 2 1.7
2. Hypertension
Transient
Persistent
6
5
1
27% Nil 0
3. Renal failure
Transient
Persistent
10
9
1
45% 16
16
14
          Atypical manifestations like hematuria, hypertension and renal failure are found to 
be more common in steroid resistant nephrotic syndrome. The reason behind this may be 
that  SRNS produces  structural  damage  to  the  kidney  unlike  MCN where  the  basic 
pathology  is  only  the  loss  of  negatively  charged  glycosaminoglycons.   32% (7)  of 
children with steroid resistance had hematuria as compared to 1.7 % (2) in responsive 
group. 
Hypertension at the onset was documented in 27% (6) of children with resistance. 
These children were treated with short  term methyl  dopa;  out  of  this  one child had 
persistent hypertension and progressed to chronic renal failure.
Elevated renal parameter was noticed in 45% (10) of patients with resistance and 
14% (16) of patients in response group. One child required peritoneal dialysis. Child 
who  developed  chronic  renal  failure  is  under  follow  up.  These  factors  predict  the 
development of resistance with statistical significance (p<0.05).  
Serum albumin level in steroid resistant and 
responsive nephrotic syndrome
Table 6
Serum level 
(g/dl)
Steroid responsive 
(n=112) Steroid resistant (n=22)
Number % Number %
>2.5 11 10 2 9
1.5 – 2.5 101 90 19 86
<1.5 Nil 0 1 5
Serum cholesterol level in both groups
Table 7
Serum 
level(mg/dl)
Steroid resistant
(No = 22)
Steroid responsive
(No =112)
No of cases % No of cases %
200-300 1 5 13 12
300-400 8 36 57 51
400-500 8 36 25 22
500-600 4 18 12 11
>600 1 5 5 4
          Serum albumin is found to be low in (<2.5gm/dl) in both groups. Even though 
serum cholesterol is found to be high with resistant group than in responsive group, 
statistically  the difference is  insignificant  (p>0.05).  In children with steroid resistant 
nephrotic syndrome hypoalbuminemia was found in 91 % (20) of patient as against 90 
% (101) of patients with responsive group and serum cholesterol >400mg/dl was found 
in 59 % of patients with SRNS as against 37 % in response group.              
Thus the value of serum albumin and serum cholesterol levels will not give a clue 
to the type of nephrotic syndrome. 
Type of infections in both groups
Table 8
Infection
Steroid resistant (n=22) Steroid responsive (n=112)
No. of cases % No. of cases %
UTI 6 27 13 11
LRI 2 9 2 2
Peritonitis 1 4.5 - -
Tuberculosis - - 2 2
          Urinary tract infection is more common in steroid resistant nephrotic syndrome 
27% (6) than responsive group 11% (13).
          The reason for this difference is not known. One child developed peritonitis in 
resistant group and two children in responsive group showed positive mantoux. RGJ 
(resting gastric juice) for AFB (acid fast bacilli) was done in positive mantoux cases 
which  were  negative.  They  received  anti  tuberculosis  treatment  according  to  IAP 
recommendation. 4 children had respiratory infection, two in each group.
Ultrasound findings in both groups
Table 9
USG
Steroid resistant (n=22) Steroid responsive(n=112)
No. of cases % No. of cases %
Normal 7 32 84 75
Grade 1 RPD 7 32 26 23
Grade 2 RPD 8 36 2 2
   Abnormal ultrasound findings in the form of grade 1 or grade 2 RPD was seen 
in 68% (15) of children with steroid resistant nephrotic syndrome as against 25% (28) in 
responsive group (p<0.05).
X ray findings in both groups
Table 10
CXR
Steroid Resistant (n=22) Steroid Responsive(n=112)
No. of cases % No. of cases %
Normal 14 63.6 97 87
Pleural 
effusion 8 36.4 15 13
          Pleural effusion was found in 36.4 % (8) of children with resistant nephrotic 
syndrome  and  was  13  %  (15)  in  responsive  group  (p<0.05).  From  this  it  can  be 
concluded  that  in  the  presence  of  abnormal  radiological  features  in  a  child  with 
nephrotic syndrome then, the probability of having a SRNS is high. 
Table 11
Steroid responsive 
nephrotic 
syndrome
Steroid resistant 
Nephrotic 
syndrome
No. of 
cases %
No. of 
cases %
p-value+
Age
<1 year
1 – 3 years
4 – 6 years
7 – 9 years
10 – 12 years
3
42
32
23
12
50
57
64
57
80
1
8
7
5
1
25.0
16.0
17.9
17.9
7.7
0.90
Sex
Male
Female
39
73
83.0
83.9
8
14
17.0
16.1
1.00
Hematuria
Absent
Present
110
2
88.0
22.2
15
7
12.0
77.8
0.00
Hypertension
Absent
Present
112
-
87.5
-
16
6
12.5
100.0
0.00
UTI
Absent
Present
99
13
86.1
68.4
16
6
13.9
31.6
0.09
Urea
<40 mg/dl  
41 - 100mg/dl 
101-200mg/dl
96
16
89.7
61.5
11
10
10.3
38.5
0.00*
- - 1 100.0
Creatinine
<1mg/dl      
1-2 mg/dl
106
6
89.8
37.5
12
10
10.2
62.5
0.00
Albumin
>2.5  gm/dl 
1.5 –2.5 gm/dl 
<1.5 gm/dl
11
101
-
84.6
84.2
-
2
19
1
15.4
15.8
100.0
0.08
Cholesterol
200-300mg/dl 
300-400mg/dl
400-500mg/dl 
500-600mg/dl
>600mg/dl
13
57
25
12
5
92.9
87.7
75.8
75.0
83.3
1
8
8
4
1
7.1
12.3
24.2
25.0
16.7
0.41
Mantoux
Negative
Positive
110
2
83.3
11.2
22
-
16.7
-
1.00
USG
Normal   
Grade I RPD
Grade II RPD
84
26
2
92.3
78.8
20.0
7
7
8
7.7
21.2
80.0
0.00*
Chest x-ray 
Normal 
Pleuraleffusion
97
15
87.4
65.2
14
8
12.6
34.8
0.03
*Chi-square for trend
+Chi-square
Univariate Logistic Regression
O.R. 95% C.I. p-value
Hematuria
   Absent
   Present
1.0
25.7
Reference
4.9 , 135.2
0.00
Urea
     <40 mg/dl
     >40 mg/dl
1.0
6.0
Reference
2.2 , 16.1
0.00
Creatinine
     <1mg/dl
    1-2 mg/dl
1.0
14.7
Reference
4.5 , 47.7
0.00
USG   
   Normal
   RPD
1.0
6.4
Reference
2.4 , 17.4
0.00
Chest x-ray
   Normal
   Pleural effusion
1.0
3.7
Reference
1.3 , 10.3
0.01
          Hematuria was observed in 7 out of 22 children with steroid resistant nephrotic 
syndrome when compared to 2 out of 112 among steroid sensitive nephrotic syndrome. 
Odds ratio of having hematuria is 25.7 among steroid resistant nephrotic children when 
compared to steroid responsive children {OR 95% CI (25.7 &4.9, 135.2)}
          Serum urea level was >40mg/dl in 11/22 children with steroid resistant nephrotic 
syndrome when compared to 16/112 among steroid sensitive nephrotic syndrome.  Odds 
ratio  of  having  serum  urea  level  >40mg/dl  is  6  among  steroid  resistant  nephrotic 
children when compared to steroid responsive children {OR 95% CI (6&2.2, 16.1)} 
          Serum creatinine level was more than 1 mg/dl in 12 out of 22 children in steroid 
resistant group when compared to 6 out of 112 among steroid sensitive group. 
Odds  ratio  of  having  serum  creatinine  level  >1mg/dl  is  14  
{OR 95% CI (14.7&4.5, 47.7)}.
USG  shows  RPD  in  15  out  of  22  children  with  steroid  resistant  nephrotic 
syndrome and 28 out of 112 among steroid sensitive nephrotic syndrome. Odds ratio of 
children showing RPD in USG is 6.4 {OR 95% CI (6.4&2.4, 17.4)}
Chest X ray showed pleural effusion in 8 out of 22 children with steroid resistant 
nephrotic  syndrome and 15 out  of  112 among steroid sensitive nephrotic syndrome. 
Odds ratio  of  children showing pleural  effusion in chest  X ray is  3.7 {OR 95% CI 
(3.7&1.3, 10.3)} 
Multiple Logistic Regression
O.R. 95% C.I. p-value
Urea
     <40 mg/dl
     >40 mg/dl
1.0
4.7
Reference
1.6 , 13.5
0.004
USG   
   Normal
   RPD
1.0
5.3
Reference
1.9 , 14.9
0.002
Histopathological findings in steroid resistant nephrotic syndrome
S.NO. Type
Steroid resistant
No .of cases %
1.
2.
3.
4.
5.
6.
MCN
FSGS
DMP
MPGN
Membranous
Biopsy not done
3
6
8
-
1
4
14
27
36
-
5
18
Histopathological type
          DMP is the commonest type other than MCN found in this study. It constitutes 
9% of the patients in contrast to other studies, where it constitutes only 2.3 to 5.3%. It 
forms 36% of all patients with steroid resistant nephrotic syndrome followed by FSGS 
that comprises 27% of patients with resistant nephrotic syndrome and 14% MCN type. 
Even though the distribution of various types differs slightly with other studies the 
more striking difference in this study is the occurrence of a significant proportion of 
cases with DMP
SUMMARY
1. Nephrotic syndrome is the second commonest renal problem in children preceded by 
acute  nephritic  syndrome.  It  constitutes  9% of  patients  attending  the  nephrology 
outpatient.
2. The higher age of onset for SRNS than responsive nephrotic syndrome noted in other 
studies was not noticed in this study. Males are affected more than females in both 
groups (2:1).
3. Atypical  manifestations  like  hematuria,  hypertension  and  renal  failure  are  more 
common in resistant nephrotic syndrome and they predict development of resistance 
as well.
4. The  incidence  of  hypoalbuminemia  and  hypercholesterolemia  are  same  in  both 
groups and these are poor predictors of the type.
5. Radiology plays a significant role in predicting steroid resistance. USG of kidney 
is abnormal in significantly more number of patients with SRNS. Pleural effusion 
is more common in resistant group than responsive group
6. Urinary tract infection is more common in steroid resistant nephrotic syndrome.
7. DMP  is  the  commonest  non  minimal  lesion  and  it  is  the  commonest 
histopathological type in SRNS followed by FSGS and MCN. 
                                         CONCLUSION
Presence of hematuria, hypertension, and elevated renal parameters in the initial 
presentation  with  abnormal  ultrasound  findings  predicts  the  future  development  of 
steroid resistance. Hence these children should be monitored periodically.
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